|±¾ÆÚĿ¼/Table of Contents|

[1]³ÂæÂæÂ,ÕÔÀö×ÛÊö,Íô·¼Ô£,µÈ.ÉÏÏû»¯µÀ¿ËÂÞ¶÷²¡µÄÁÙ´²ÌØÕ÷¼°ÕïÖÎÏÖ×´Óë·ÖÎö[J].ҽѧÑо¿ÓëÕ½´´É˾ÈÖÎ(ԭҽѧÑо¿Éúѧ±¨),2020,22(4):385-389.[doi:10.3969/j.issn.1672-271X.2020.04.011]
¡¡CHEN Yuan-yuan,ZHAO Li reviewing,WANG Fang-yu,et al.Clinical characteristics, diagnosis and treatment status and analysis of Crohn¡¯s disease with upper gastrointestinal tract phenotype[J].JOURNAL OF MEDICALRESEARCH ¡ªCOMBAT TRAUMA CARE,2020,22(4):385-389.[doi:10.3969/j.issn.1672-271X.2020.04.011]
µã»÷¸´ÖÆ

ÉÏÏû»¯µÀ¿ËÂÞ¶÷²¡µÄÁÙ´²ÌØÕ÷¼°ÕïÖÎÏÖ×´Óë·ÖÎö()

¡¶Ò½Ñ§Ñо¿ÓëÕ½´´É˾ÈÖΡ·£¨Ô­Ò½Ñ§Ñо¿Éúѧ±¨£©[ISSN:1672-271X/CN:32-1713/R]

¾í:
µÚ22¾í
ÆÚÊý:
2020Äê4ÆÚ
Ò³Âë:
385-389
À¸Ä¿:
×ÛÊö
³ö°æÈÕÆÚ:
2020-07-20

ÎÄÕÂÐÅÏ¢/Info

Title:
Clinical characteristics, diagnosis and treatment status and analysis of Crohn¡¯s disease with upper gastrointestinal tract phenotype
×÷Õß:
³ÂæÂæÂÕÔÀö×ÛÊöÍô·¼Ô£Áõ¾¼ÉóУ
×÷Õßµ¥Î»£º233030 °ö²º£¬°ö²ºÒ½Ñ§Ôº£¨³ÂæÂæ¡¢ÕÔÀö£©£»210002 ÄϾ©£¬¶«²¿Õ½Çø×ÜÒ½Ôº£¨Ô­ÄϾ©¾üÇøÄϾ©×ÜÒ½Ôº£©Ïû»¯ÄÚ¿Æ£¨Íô·¼Ô£¡¢Áõ¾¼£©
Author(s):
CHEN Yuan-yuan1 ZHAO Li1 reviewing WANG Fang-yu2 LIU Jiong checking2
(1.School of Graduate, Bengbu Medical College, Bengbu 233030, Anhui, China; 2.Department of Gastroenterology, General Hospital of Eastern Theater Command, PLA, Nanjing 210002, Jiangsu, China)
¹Ø¼ü´Ê:
ÉÏÏû»¯µÀ¿ËÂÞ¶÷²¡ÁÙ´²ÌØÕ÷Õï¶ÏÖÎÁÆ
Keywords:
upper digestive tract Crohn¡¯s diseaseclinical features diagnosis treatment
·ÖÀàºÅ:
R572.3
DOI:
10.3969/j.issn.1672-271X.2020.04.011
ÎÄÏ×±êÖ¾Âë:
A
ÕªÒª:
ÉÏÏû»¯µÀ¿ËÂÞ¶÷²¡ÊÇÒ»ÖÖ±¨µÀ²»×㣬ÈÏʶ²»×ãµÄ¿ËÂÞ¶÷²¡±íÐÍ¡£³ÉÈË¿ËÂÞ¶÷²¡»¼ÕßÀÛ¼°ÉÏÏû»¯µÀʱ£¬ÍùÍùԤʾ²¡ÇéÑÏÖØ¡£Î¸¾µ¼ì²éºÍ»î¼ìÊÇ×îÃô¸ÐµÄÕï¶Ï¼ì²é¡£Ä¿Ç°¹ØÓÚÉÏÏû»¯µÀ¿ËÂÞ¶÷²¡È±·¦ÓÐЧµÄÖÎÁÆ·½·¨£¬ÏȸøÓè¾Ö²¿ÖÎÁÆ£¬ÔÙ½øÕ¹µ½È«ÉíÖÎÁÆ£¬µ±»¼Õß³öÏÖ²¢·¢Ö¢ÈçÑÏÖصĹ£×èºÍ´©¿×¡¢³öѪʱ£¬ÔòÐèÒªÍâ¿Æ¸ÉÔ¤£¬Ô¤ºó²»Á¼£¬Î£º¦»¼ÕßµÄÉíÐĽ¡¿µ¡£ÎÄÕÂÖ÷Òª¾ÍÉÏÏû»¯µÀ¿ËÂÞ¶÷²¡´Ó¿ÚÇ»ÖÁÊ®¶þÖ¸³¦¸÷¸ö²¿Î»¿ËÂÞ¶÷²¡µÄÌØÕ÷¡¢ÕïÖÎÏÖ×´¼°Õ¹Íû½øÐÐ×ÛÊö¡£
Abstract:
Upper gastrointestinal Crohn¡¯s disease (CD) is an under-reported and under-recognized crohn¡¯s disease phenotype. Adult CD patients with upper gastrointestinal involvement tend to predict a more severe crohn phenotype and a higher incidence of complications.Gastroscopy and biopsy are the most sensitive diagnostic tests. Currently, there is a lack of relevant research on crohn¡¯s treatment of upper gastrointestinal tract. Treatment management is similar to that of ileocolic CD. Local treatment is given first, and then the treatment progresses to systemic treatment. When patients suffer from complications such as severe obstruction, perforation and bleeding, surgical intervention is required, and the prognosis is poor, endangering the physical and mental health of patients. This paper aims to summarize the characteristics, diagnosis and treatment status and prospects of the CD in various parts of upper gastrointestinal crohn¡¯s disease from oral cavity to duodenum.

²Î¿¼ÎÄÏ×/References:

[1]Sun XW, Wei J, Yang Z, et al. Clinical Features and Prognosis of Crohn¡¯s Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients[J]. Dig Dis Sci,2019, 64(11): 3291-3299.
[2]Laube R, Liu K, Schifter M, et al. Oral and upper gastrointestinal Crohn¡¯s disease[J]. J Gastroenterol Hepatol, 2018,3(2):355-364.
[3]Öìΰ˼. ÉÏÏû»¯µÀ¿ËÂÞ¶÷²¡ÁÙ´²ÌØÕ÷¼°ÕïÁÆÏÖ×´·ÖÎö[D]. ¹ãÖÝ£ºÄÏ·½Ò½¿Æ´óѧ, 2015.
[4]Pimentel AM,Rocha R,Santana GO, et al. Crohn¡¯s disease of esophagus, stomach and duodenum[J]. World J Gastrointest Pharmacol Ther, 2019,10(2): 35-49.
[5]Tan CX, Brand HS, de Boer NK, et al.Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn¡¯s disease[J]. Br Dent J, 2016,221(12): 794-799.
[6]Tan CXW,de Boer NKH,Brand HS, et al. Oral manifestations of Crohn¡¯s disease[J]. Ned Tijdschr Tandheelkd, 2018, 125(1): 15-20.
[7]Schwartzberg DM,Brandstetter S,Grucela AL, et al. Crohn¡¯s Disease of the Esophagus, Duodenum, and Stomach[J]. Clin Colon Rectal Surg, 2019,32(4): 231-242.
[8]Davis KG. Crohn¡¯s Disease of the Foregut[J]. Surg Clin North Am, 2015,95(6): 1183-1193.
[9]Greuter T, Piller A,Fournier N, et al. Upper Gastrointestinal Tract Involvement in Crohn¡¯s Disease: Frequency, Risk Factors, and Disease Course[J]. J Crohns Colitis, 2018, 12(12): 1399-1409.
[10]De Felice KM, Katzka DA, Raffals LE. Crohn s Disease of the Esophagus:Crohn¡¯s Disease of the Esophagus: Clinical Features and Treatment Outcomes in the Biologic Era[J]. Inflamm Bowel Dis, 2015,21(9): 2106-2113.
[11]Nomura Y, Moriichi K, Fujiya M, et al. The endoscopic findings of the upper gastrointestinal tract in patients with Crohn¡¯s disease[J]. Clin J Gastroenterol, 2017,10(4): 289-296.
[12]Singh A,Agrawal N,Kurada S,et al. Efficacy, Safety, and Long-term Outcome of Serial Endoscopic Balloon Dilation for Upper Gastrointestinal Crohn¡¯s Disease-associated Strictures-A Cohort Study[J]. J Crohns Colitis, 2017, 11(9):1044-1051.
[13]Sato Y,Matsui T,Yano Y,et al. Long-term course of Crohn¡¯s disease in Japan: Incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery[J]. J. Gastroenterol Hepatol,2015,30(12):1713-1719.
[14]Lightner AL,Fletcher JG. Duodenal Crohn¡¯s Disease-a Diagnostic Conundrum[J]. J Gastrointest Surg, 2018,22(4):761-763.
[15]Ooi CJ,Makharia GK,Hilmi I,et al. Asia Pacific Consensus Statements on Crohn¡¯s disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn¡¯s Disease Consensus--Part 1)[J]. J Gastroenterol Hepatol, 2016,31:45-55.
[16]Mentzer A,Nayee S,Omar Y,et al. Genetic Association Analysis Reveals Differences in the Contribution of NOD2 Variants to the Clinical Phenotypes of Orofacial Granulomatosis[J]. Inflamm Bowel Dis, 2016,22:1552-1558.
[17]Farkas K, Chan H, Rutka M, et al. Gastroduodenal involvement in asymptomatic Crohn¡¯s Disease patients in two areas of emerging disease: Asia and Eastern Europe[J]. J Crohns Colitis,2016, 10(12): 1401-1406.
[18]Grand D, Guglielmo F, Al-Hawary M. MR enterography in Crohn¡¯s Disease: current consensus on optimal imaging technique and future advances from the SAR Crohn¡¯s Disease-focused pannel[J]. Abdom Imaging, 2015,40:953-964.
[19]Ooi C, Makharia G, Hilmi I, et al. Asia-Pacific consensus statements on Crohn¡¯s disease. Part 2: Management[J]. J Gastroenterol Hepatol, 2016,31:56-68.
[20]Îâ»ÛÃô£¬Íô·¼Ô£.µ°°×øÓë×ÔÉíÏû»¯ÔÚÑ×Ö¢ÐÔ³¦²¡·¢Éú»úÖÆÖеÄ×÷ÓÃÓëÆôʾ[J]. ҽѧÑо¿Éúѧ±¨,2019,32(6):561-565.
[21]D¥hbkowski K,Graca-Pakulska K,Zawada I,et al. Clinical significance of endoscopic findings in the upper gastrointestinal tract in Crohn¡¯s disease[J]. Scand J Gastroenterol,2019, 54(9): 1075-1080.
[22]Ó¡ÖÐÅô£¬ËÎÁîÐÛ£¬ÍõËÕÃΣ¬µÈ. Ѫ½¬¿¹ÄýѪø¢óºÍѪÇåIL-6Óë½µ¸ÆËØÔ­¶ÔÅжϿËÂÞ¶÷²¡»î¶¯ÐÔµÄÁÙ´²¼ÛÖµ[J]. ¶«ÄϹú·ÀÒ½Ò©, 2018, 20(1): 22-25.
[23]¸ß´³£¬¶ÅÏþ²©£¬Íõµ¤µ¤£¬µÈ. °×ϸ°û½éËØ22ÓëÑ×Ö¢ÐÔ³¦²¡µÄÑо¿½øÕ¹[J]. ҽѧÑо¿Éúѧ±¨, 2018, 31(11): 1196-1200.
[24]Cazacu SM,Ghilu ÿðþ ‰D i MC,Ivan ET,et al. An unusual onset of Crohn¡¯s disease with oral aphthosis, giant esophageal ulcers and serological markers of cytomegalovirus and herpes virus infection: a case report and review of the literature.[J]. Rom J Morphol Embryol, 2019, 60(2): 659-665.
[25]Bettenworth D,M¨¹cke MM,Lopez R,et al. Efficacy of Endoscopic Dilation of Gastroduodenal Crohn¡¯s Disease Strictures: A Systematic Review and Meta-Analysis of Individual Patient Data.[J]. Clin Gastroenterol Hepatol,2019,17(12): 2514-2522.
[26]Iborra M,Juli¨¢ B,Mart¨ªn Arranz MD,et al. Management and outcomes of patients with Crohn¡¯s disease with first vs multiple surgeries: results from the PRACTICROHN study[J]. Gastroenterol Rep, 2019, 7(6): 411-418.

ÏàËÆÎÄÏ×/References:

[1]Ѧ ËÉ,κ ÀÚ,³Ì ÎÄ,µÈ.¿ËÂÞ¶÷²¡°òë×ðü3Àý±¨¸æ[J].ҽѧÑо¿ÓëÕ½´´É˾ÈÖÎ(ԭҽѧÑо¿Éúѧ±¨),2013,15(01):64.
[2]Íõçæ,Ðì½ðÖÐ,»ÆÓ­´º,µÈ.Íâ¿Æ¼ÓËÙ¿µ¸´ÍŶÓÔÚ»¤Àí¿ËÂÞ¶÷²¡»¼ÕßÖеÄÓ¦ÓÃÓëЧ¹û¹Û²ì[J].ҽѧÑо¿ÓëÕ½´´É˾ÈÖÎ(ԭҽѧÑо¿Éúѧ±¨),2017,19(03):311.[doi:10.3969/j.issn.1672-271X.2017.03.023]
[3]Ó¡ÖÐÅô,ËÎÁîÐÛ,ÍõËÕÃÎ,µÈ.Ѫ½¬¿¹ÄýѪø¢óºÍѪÇåIL-6Óë½µ¸ÆËØÔ­¶ÔÅжϿËÂÞ¶÷²¡»î¶¯ÐÔµÄÁÙ´²¼ÛÖµ[J].ҽѧÑо¿ÓëÕ½´´É˾ÈÖÎ(ԭҽѧÑо¿Éúѧ±¨),2018,20(01):22.[doi:10.3969/j.issn.1672-271X.2018.01.005]
¡¡YIN Zhong-peng,SONG Ling-xiong,WANG Su-meng,et al.Clinical value of plasma AT-¢ó and serum PCT, IL-6 levels and the evaluations of disease activity in Crohn¡äs disease[J].JOURNAL OF MEDICALRESEARCH ¡ªCOMBAT TRAUMA CARE,2018,20(4):22.[doi:10.3969/j.issn.1672-271X.2018.01.005]
[4]·îæº,κ¾ê,Íô·¼Ô£.¿ËÂÞ¶÷²¡ºÏ²¢¸¹ÅèǻŧÖ×µÄÄÚ¿ÆÖÎÁƽøÕ¹[J].ҽѧÑо¿ÓëÕ½´´É˾ÈÖÎ(ԭҽѧÑо¿Éúѧ±¨),2022,24(1):54.[doi:10.3969/j.issn.1672-271X.2022.01.012]
¡¡FENG Jing,WEI Juan,WANG Fang-yu.Progress in medical treatment of abdominal and pelvic abscess in Crohn¡¯s disease[J].JOURNAL OF MEDICALRESEARCH ¡ªCOMBAT TRAUMA CARE,2022,24(4):54.[doi:10.3969/j.issn.1672-271X.2022.01.012]

±¸×¢/Memo

±¸×¢/Memo:
»ù½ðÏîÄ¿£º¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¨81873559£©
¸üÐÂÈÕÆÚ/Last Update: 2020-07-13